Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$77,590
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$78K 10% owner 2 filings
Date Insider Transaction Shares Price Value Owned after
2026-08-10 Simcere Zaiming, Inc. Former 10% Owner Sale −30,000 $6.16 $185K 308,636

Page 1 of 1 · 1 trade